Sort
82,697 grants matching “vaccine development”
MBRS-SCORE PROGRAM AT UPR, MEDICAL SCIENCES CAMPUS
$2,130,079University Of Puerto Rico Med Sciences · S06 · FY2000 · GM
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,129,021Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Development of a Safe and Effective Vaccine Against West Nile Virus
$2,128,280Mark K Slifka · Oregon Health & Science University · U01 · FY2010 · AI
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,128,063Dana-Farber Cancer Institute · P01 · FY2004 · CA
RPCI-UPCI Ovarian Cancer SPORE
$2,128,000Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2015 · CA
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$2,127,511Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI
Genetic screens for key transcriptional regulators of antiviral T cell immunity
$2,127,090Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2015 · AI
Pacific Center for Emerging Infectious Diseases Research
$2,126,915Richard Yanagihara · University Of Hawaii At Manoa · P20 · FY2010 · RR
Increasing financial and health equity among low income black youth and young adults
$2,126,891Sheri Ann Lippman · University Of California, San Francisco · U01 · FY2024 · MD
Vermont Immunobioloigy/ Infectious Diseases Center
$2,126,776Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2013 · GM
COBRE:Eukaryotic Pathogens Innovation Center (EPIC)
$2,126,626Lesly A Temesvari · Clemson University · P20 · FY2016 · GM
Rhinovirus Infections and Childhood Asthma
$2,126,484Robert F Lemanske · University Of Wisconsin-Madison · P01 · FY2010 · HL
Rhinovirus Infections and Childhood Asthma
$2,126,484Robert F Lemanske · University Of Wisconsin-Madison · P01 · FY2011 · HL
Rhinovirus Infections and Childhood Asthma
$2,126,340Robert F Lemanske · University Of Wisconsin-Madison · P01 · FY2009 · HL
T Cell Memory to Pathogens: Generation and Function
$2,126,315Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
Cellular and Molecular Defects in Human B Cell Development
$2,125,273Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,125,238Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Natural History of HPV Infection in Men: The HIM Study
$2,125,167Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2007 · CA
Protective immunity following dengue virus natural infections and vaccination
$2,125,099Eva Harris · University Of California Berkeley · P01 · FY2018 · AI
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,124,914Scott M Hammer · Columbia University Health Sciences · UM1 · FY2015 · AI
HPV Serology
$2,124,864Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
The Gonorrhea Vaccine Cooperative Research Center
$2,124,757Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2021 · AI
Optimizing HIV immunogen-BCR interactions for vaccine development
$2,124,372Leonidas A Stamatatos · Seattle Biomedical Research Institute · P01 · FY2013 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,124,233Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2021 · AI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,123,313Pamela J Bjorkman · California Institute Of Technology · P01 · FY2013 · AI